Contractor
AMGEN USA INC
THOUSAND OAKS, CA
- UEI
- XPGNQMXHP493
- Parent UEI
- Y6NEW42XK544
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$839,875,1901
Awards
3
Agencies served
2
Active from Sep 28, 2022 to Aug 4, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75A50122C00065 TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN. | Department of Health and Human Services | CA | Sep 28, 2022 | $839,875,190 |
| 36F79721D0086 NDC CHANGES | Department of Veterans Affairs | — | Mar 4, 2026 | — |
| 36E79725D0053 ADD NEW NDC FOR 420MG ON AMGEN NATIONAL CONTRACT FOR TRASTUZUMAB. | Department of Veterans Affairs | — | Mar 11, 2026 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier XPGNQMXHP493, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.